Stock market outlook for the week: Inflation, corporate earnings and more in focus; key factors to look out for

Indian markets brace for a crucial week, with investors keenly awaiting inflation figures and corporate earnings from giants like ONGC and Asian Paints. Global factors, including the US shutdown and trade talks, alongside foreign investor activity and currency movements, will also steer market direction. Last week saw a dip in major indices.

Read More

Perth-born Ryan Williams joins Indian football camp after giving up Australian passport, eyes India debut vs Bangladesh

Australia-born forward Ryan Williams has officially joined the Indian national football team camp in Bengaluru. Having recently acquired Indian citizenship, Williams’ inclusion marks a significant step for the team ahead of their AFC Asian Cup qualifier. The 32-year-old, who plays for Bengaluru FC, brings international experience and technical ability to the squad.

Read More

R. Madhavan’s first glimpse from ‘Dhurandhar’ looks fierce, ‘The Charioteer of Karma’; Ranveer Singh REACTS

Fans are buzzing as R. Madhavan’s intense first look as a potential National Security Advisor in ‘Dhurandhar’ has been revealed. Following Arjun Rampal’s fierce portrayal, Madhavan’s transformation has impressed many. The trailer for this true-event-inspired spy thriller, starring Ranveer Singh, drops November 12th, with the film releasing December 5th.

Read More

Tech push: Assam to join global semiconductor map by 2026; FM Sitharaman reviews Rs 27,000 cr Tata OSAT project

Finance Minister Nirmala Sitharaman reviewed Tata Electronics’ Rs 27,000 crore semiconductor facility in Assam, a significant step towards global integration by 2026. This project, expected to create over 25,000 jobs, aims to transform the state into an advanced electronics manufacturing hub, marking a new era for Northeast India’s economic growth and technological advancement.

Read More

Diabetes drug cancelling your workout gains? Study explains why

A Rutgers study reveals that metformin, a common diabetes drug, may counteract the benefits of exercise. Researchers found the medication blunts improvements in blood vessel function, fitness, and blood sugar control typically achieved through physical activity. These findings challenge the long-held assumption that combining metformin and exercise offers additive benefits for chronic disease prevention.

Read More